BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 19513549)

  • 61. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
    Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A
    Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
    Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
    J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies.
    El-Masry S; El-Sayed IH; Lotfy M; Mahmoud L; El-Naggar M
    J Immunoassay Immunochem; 2007; 28(2):91-105. PubMed ID: 17424828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum levels of bcl-2 in patients with colorectal cancer.
    Giannoulis K; Fountzilas G; Angouridakis N; Angouridaki C; Giannoulis E; Gamvros O
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s56-8. PubMed ID: 15655644
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identifying markers for pancreatic cancer by gene expression analysis.
    Zhou W; Sokoll LJ; Bruzek DJ; Zhang L; Velculescu VE; Goldin SB; Hruban RH; Kern SE; Hamilton SR; Chan DW; Vogelstein B; Kinzler KW
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):109-12. PubMed ID: 9488584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer.
    Kobayashi Y; Niwa Y; Tajika M; Kawai H; Kondo S; Hara K; Mizuno N; Hijioka S; Sawaki A; Matsuo K; Nakagawa H; Nakamura Y; Yamao K
    Hepatogastroenterology; 2010; 57(104):1631-4. PubMed ID: 21443133
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
    Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
    Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
    Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
    Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer.
    Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Ishigami S; Owaki T; Takao S; Aikou T
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5972-7. PubMed ID: 17062668
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.
    Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G
    Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer.
    Bünger S; Haug U; Kelly FM; Klempt-Giessing K; Cartwright A; Posorski N; Dibbelt L; Fitzgerald SP; Bruch HP; Roblick UJ; von Eggeling F; Brenner H; Habermann JK;
    J Biomol Screen; 2011 Oct; 16(9):1018-26. PubMed ID: 21807963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer].
    Takahashi K; Hiramatsu K; Kawakita M; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Tamamori Y
    Rinsho Byori; 2004 Apr; 52(4):332-5. PubMed ID: 15164601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.